A new class of living medicines and consumer innovations to modulate the vaginal microbiota
all companies
milestones
Founded 2020
Partnered 2020
Team
Jacques Ravel
Ara Katz
Raja Dhir
Board
LEAD INVESTOR
Stuart Peterson
category
Women's Health
Infectious
Developing live biotherapeutics to protect against vaginal dysbiosis and restore homeostatic function to the vaginal microbiome
No items found.
